About this trial
Dental manufacturers\' constant tweaks and improvements to composite compositions have resulted in a wider spectrum of restorative materials with positive long-term clinical performance. For example, the creation of bioactive giomer material with proven continuous multi-ion release has been beneficial in avoiding demineralization and imparting acid resistance to enamel and dentin.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18 -35 years.
Not received antibiotic therapy since 1 month before sampling.
Males or Females (Both genders).
Co-operative patients approving the trial.
Disqualifiers
known allergic reaction to resinous materials.
Systemic disease or severe medical complications.
Periodontal problem.
Bruxism
Trial design
Parallel
Treatments tested in this trial
Beautifil II LS (Low-Shrinkage)
Procedure/SurgeryThe most remarkable feature of this light-cured universal composite for anterior and posterior restorations is its unique shrinkage of 0.85 percent by volume
Nanohybrid resin composite
Procedure/SurgeryNanohybrid resin composites are the most popular, because they improve the distribution of fillers in the matrix by combining nanoparticles with submicron particles to achieve better mechanical, chemical, and optical properties
Treatment groups
Trial outcomes
Primary outcomes
Success rate
The primary outcome of the present clinical trial is success rate, expressed as a binary variable indicating whether the restored tooth maintained its pulp vitality after 24 months. Success will be evaluated by a positive response to cold pulp testing, absence of spontaneous pain, no tenderness to percussion, absence of periapical radiolucency.
Secondary outcomes
Dentin bridge formation
Dentin bridge formation will be evaluated by digital radiographs taken with standardized exposure parameters according to standardized procedure by placement of film holders in paralleling technique. Dentin bridge formation will be measured by millimeters (mm)
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: